n,n-dimethylarginine has been researched along with technetium tc 99m sestamibi in 1 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (technetium tc 99m sestamibi) | Trials (technetium tc 99m sestamibi) | Recent Studies (post-2010) (technetium tc 99m sestamibi) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 5,774 | 627 | 1,208 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aşik, M; Aslantaş, Y; Bulur, S; Doğan, AS; Erkan, ME; Ilçe, HT; Memişoğullari, R; Uçgun, T; Yildirim, M; Yildiz, N; Yilmaz, A | 1 |
1 other study(ies) available for n,n-dimethylarginine and technetium tc 99m sestamibi
Article | Year |
---|---|
Asymmetric dimethylarginine is not a good predictor of ischemia using myocardial perfusion scintigraphy.
Topics: Arginine; Coronary Artery Disease; Echocardiography; Female; Humans; Ischemia; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2015 |